OnKure Therapeutics Inc.

NASDAQ: OKUR · Real-Time Price · USD
2.53
-0.14 (-5.24%)
At close: Aug 15, 2025, 3:59 PM
2.44
-3.63%
After-hours: Aug 15, 2025, 07:38 PM EDT

OnKure Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
110.76M 29.88M 11.54M 124.66M
Short-Term Investments
n/a n/a 81.25M 23.01M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
109K 58K 329K 78K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a 840K 6.06M
Total Current Assets
113M 33.77M 13.62M 153.73M
Property-Plant & Equipment
1.79M 1.91M 2.05M 212K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.9M 1.97M 2.38M 290K
Total Assets
114.91M 35.73M 16M 154.02M
Account Payables
2.97M 3.42M 2.52M n/a
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
536K 208K 404K n/a
Other Current Liabilities
2.64M 1.46M 1.05M 6.2M
Total Current Liabilities
10.53M 7.29M 5.54M 6.2M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 129.82M 64.39M 444K
Total Long-Term Liabilities
549K 130.29M 64.88M 611K
Total Liabilities
11.08M 137.58M 70.42M 6.81M
Total Debt
1.08M 674K 637K n/a
Common Stock
1K n/a 1K 3K
Retained Earnings
-154.72M -102.05M -57.07M -84.73M
Comprehensive Income
n/a n/a -43K 34K
Shareholders Equity
103.83M -101.84M -54.42M 147.21M
Total Investments
n/a n/a 81.25M 23.01M